BioTech/Drugs - Cambridge, MA, US
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.
Outlook
Microsoft Office 365
Google Cloud Hosting